Literature DB >> 34079715

Utility of noncontrast MRI in the detection and risk grading of gastrointestinal stromal tumor: a comparison with contrast-enhanced CT.

Ziling Zhou1, Jingyu Lu1, John N Morelli2, Daoyu Hu1, Zhen Li1, Peng Xiao3, Xuemei Hu1, Yaqi Shen1.   

Abstract

BACKGROUND: Recently developed adjuvant therapies for gastrointestinal stromal tumor (GIST) have been shown to improve patient survival. Guidelines currently recommend contrast-enhanced computed tomography (CECT) for GIST detection and surveillance. Patients with moderate-to-high risk GISTs require more frequent surveillance due to a higher 5-year recurrence rate. Our study aimed to compare noncontrast magnetic resonance imaging (MRI) with CECT for GIST detection, and evaluate volumetric apparent diffusion coefficients (ADCs) for risk stratification of GIST.
METHODS: We retrospectively enrolled 83 patients with histopathologically confirmed GISTs for lesion detection efficiency analysis between noncontrast MRI and matched CECT studies. A 5-point scale was used by two independent reviewers to determine if the lesion was present or absent. Another cohort, comprising 28 patients with pathologically confirmed primary GISTs, was further screened for risk stratification, with a comparison of volumetric ADC parameters between the pathologically very-low-to-low risk and moderate-to-high risk GIST patients.
RESULTS: For identifying GISTs, the sensitivity and specificity of noncontrast MRI were 83.6% and 89.3% for reader 1 respectively, and 81.8% and 92.9% for reader 2 respectively; the sensitivity and specificity of CECT were 76.4% and 89.3% for reader 1 respectively, and 76.4 and 78.6% for reader 2 respectively. Tumor volumetric ADC histogram parameters, including ADCmax, ADCstdev, 90th and 95th percentiles, inhomogeneity, and entropy, were positively correlated with a higher risk grade of GIST (r=0.421-0.758). The receiver operator characteristic curve analysis showed ADCmax achieved the highest area under the curve value of 0.938 for discriminating very-low-to-low risk versus moderate-to-high risk GISTs.
CONCLUSIONS: Noncontrast MRI was an efficient technique for identifying GIST patients. The combination of CECT and noncontrast MRI can improve the reliability of diagnosis. For patients with contraindications to CECT, noncontrast MRI may be a comparable alternative. Volumetric ADC histogram parameters may be useful in differentiating very-low-to-low risk from moderate-to-high risk primary GISTs. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Diffusion magnetic resonance imaging (diffusion MRI); gastrointestinal stromal tumor (GIST); magnetic resonance imaging (MRI); multidetector computed tomography (multidetector CT)

Year:  2021        PMID: 34079715      PMCID: PMC8107337          DOI: 10.21037/qims-20-578

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  35 in total

1.  The importance of a priori sample size estimation in strength and conditioning research.

Authors:  Travis W Beck
Journal:  J Strength Cond Res       Date:  2013-08       Impact factor: 3.775

2.  Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.

Authors:  Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae Won Kim; Hye Jin Kang; Hee Jung Sohn; Jung Shin Lee; Yoon-Koo Kang
Journal:  Jpn J Clin Oncol       Date:  2006-01-17       Impact factor: 3.019

3.  Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; N Abecassis; H T Aro; S Bauer; R Biagini; S Bielack; S Bonvalot; I Boukovinas; J V M G Bovee; T Brodowicz; J M Broto; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; P Dileo; M Eriksson; A Fedenko; V Ferraresi; A Ferrari; S Ferrari; A M Frezza; S Gasperoni; H Gelderblom; T Gil; G Grignani; A Gronchi; R L Haas; B Hassan; P Hohenberger; R Issels; H Joensuu; R L Jones; I Judson; P Jutte; S Kaal; B Kasper; K Kopeckova; D A Krákorová; A Le Cesne; I Lugowska; O Merimsky; M Montemurro; M A Pantaleo; R Piana; P Picci; S Piperno-Neumann; A L Pousa; P Reichardt; M H Robinson; P Rutkowski; A A Safwat; P Schöffski; S Sleijfer; S Stacchiotti; K Sundby Hall; M Unk; F Van Coevorden; W T A van der Graaf; J Whelan; E Wardelmann; O Zaikova; J Y Blay
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

4.  Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography.

Authors:  Nan-Jie Gong; Chun-Sing Wong; Yiu-Ching Chu; Jing Gu
Journal:  NMR Biomed       Date:  2012-07-16       Impact factor: 4.044

5.  Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.

Authors:  Christian Stroszczynski; Dominik Jost; Peter Reichardt; Petra Chmelik; Gunnar Gaffke; Albrecht Kretzschmar; Ulrike Schneider; Roland Felix; Peter Hohenberger
Journal:  Eur Radiol       Date:  2005-08-13       Impact factor: 5.315

6.  Appropriate Follow-Up Strategies for Gastrointestinal Stromal Tumor Patients Based on the Analysis of Recurrent Interval and Patterns.

Authors:  Noriko Wada; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Toru Masuzawa; Rie Nakatsuka; Junji Kawada; Toshirou Nishida; Yutaka Kimura; Kouji Tanaka; Yasuhiro Miyazaki; Tomoki Makino; Makoto Yamasaki; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Digestion       Date:  2017-02-04       Impact factor: 3.216

7.  Diagnosis of Small-Bowel Diseases: Prospective Comparison of Multi-Detector Row CT Enterography with MR Enterography.

Authors:  Gabriele Masselli; Marco Di Tola; Emanuele Casciani; Elisabetta Polettini; Francesca Laghi; Riccardo Monti; Maria Giulia Bernieri; Gianfranco Gualdi
Journal:  Radiology       Date:  2015-11-24       Impact factor: 11.105

8.  Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

Authors:  Charles D Blanke; George D Demetri; Margaret von Mehren; Michael C Heinrich; Burton Eisenberg; Jonathan A Fletcher; Christopher L Corless; Christopher D M Fletcher; Peter J Roberts; Daniela Heinz; Elisabeth Wehre; Zariana Nikolova; Heikki Joensuu
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Small-bowel neoplasms: prospective evaluation of MR enteroclysis.

Authors:  Gabriele Masselli; Elisabetta Polettini; Emanuele Casciani; Luca Bertini; Amorino Vecchioli; Gianfranco Gualdi
Journal:  Radiology       Date:  2009-03-20       Impact factor: 11.105

10.  Histological grades of rectal cancer: whole-volume histogram analysis of apparent diffusion coefficient based on reduced field-of-view diffusion-weighted imaging.

Authors:  Yang Peng; Hao Tang; Xiaoyan Meng; Yaqi Shen; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Quant Imaging Med Surg       Date:  2020-01
View more
  2 in total

1.  Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei.

Authors:  Pengtao Sun; Xinbao Li; Lingling Wang; Rengui Wang; Xuechao Du
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  High-frame-rate contrast-enhanced ultrasound findings of liver metastasis of duodenal gastrointestinal stromal tumor: A case report and literature review.

Authors:  Jia-Hui Chen; Ying Huang
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.